14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Mar 17, 2017 $24.00 $24.00 $20.00 $20.00 62 231
Mar 16, 2017 $25.00 $25.00 $23.00 $24.00 15 139
Mar 15, 2017 $25.00 $25.00 $24.00 $25.00 34 278
Mar 14, 2017 $25.00 $25.00 $24.00 $24.00 14 800
Mar 13, 2017 $23.00 $25.00 $23.00 $25.00 11 686
Mar 10, 2017 $25.00 $25.20 $22.00 $23.00 30 691
Mar 09, 2017 $27.00 $28.00 $25.00 $25.00 15 182
Mar 08, 2017 $28.00 $28.00 $26.00 $27.00 20 267
Mar 07, 2017 $28.00 $28.00 $25.00 $28.00 35 812
Mar 06, 2017 $30.00 $30.00 $25.00 $26.00 31 252
Mar 03, 2017 $28.00 $30.00 $27.00 $29.00 56 545
Mar 02, 2017 $24.00 $27.00 $23.00 $26.00 87 901
Mar 01, 2017 $23.00 $24.00 $22.40 $24.00 19 895
Feb 28, 2017 $21.00 $23.00 $21.00 $23.00 45 584
Feb 27, 2017 $24.00 $24.50 $21.00 $21.50 130 903
Feb 24, 2017 $26.00 $27.00 $24.00 $24.50 74 252
Feb 23, 2017 $31.00 $32.00 $26.00 $27.00 142 019
Feb 22, 2017 $32.00 $32.00 $25.00 $29.50 362 971
Feb 21, 2017 $96.00 $96.00 $84.00 $88.00 21 536
Feb 17, 2017 $94.00 $98.00 $93.00 $94.00 13 658
Feb 16, 2017 $95.00 $97.00 $94.00 $94.00 11 513
Feb 15, 2017 $93.00 $97.00 $93.00 $95.00 6 924
Feb 14, 2017 $98.00 $99.80 $93.00 $94.00 13 607
Feb 13, 2017 $106.00 $106.00 $98.00 $99.00 9 719
Feb 10, 2017 $101.00 $106.00 $101.00 $104.00 13 326
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT